Staphylococcus aureus (Pot.-Information) - Zoekresultaten

dalacin hart hylki 150 mg

pfizer aps - clindamycinum hýdróklóríð - hart hylki - 150 mg

dalacin hart hylki 300 mg

pfizer aps - clindamycinum hýdróklóríð - hart hylki - 300 mg

dalacin stungulyf, lausn 150 mg/ml

pfizer aps - clindamycinum fosfat - stungulyf, lausn - 150 mg/ml

meropenem sun stungulyfs-/innrennslisstofn, lausn 500 mg

sun pharmaceutical industries europe b.v. - meropenemum tríhýdrat - stungulyfs-/innrennslisstofn, lausn - 500 mg

meropenem wh (meropenem w&h) stungulyfs-/innrennslisstofn, lausn 1 g

williams & halls ehf. - meropenemum tríhýdrat - stungulyfs-/innrennslisstofn, lausn - 1 g

oftaquix augndropar, lausn 5 mg/ml

santen oy* - levofloxacinum hemihýdrat - augndropar, lausn - 5 mg/ml

oftaquix augndropar, lausn í stakskammtaíláti 5 mg/ml

santen oy* - levofloxacinum hemihýdrat - augndropar, lausn í stakskammtaíláti - 5 mg/ml

piperacillin/tazobactam wh innrennslisstofn, lausn 4 g/0,5 g

williams & halls ehf. - piperacillinum natríum; tazobactamum natríum - innrennslisstofn, lausn - 4 g/0,5 g

spectracillin filmuhúðuð tafla 875/125 mg

williams & halls ehf. - acidum clavulanicum kalíum; amoxicillinum tríhýdrat - filmuhúðuð tafla - 875/125 mg

tobradex augndropar, dreifa

novartis healthcare a/s - dexamethasonum fosfat; tobramycinum inn - augndropar, dreifa